There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
"Dutta; A,K,; et al,: Med,chem, Res,; 5; 54 (1994);carai; M,A,M,; et al,: Life ci,; 77; 2339 (2005); Despres; J,-P,; et al,: N, Engl, J, Med,; 353; 2121 (2005);"
Synonyms
Ribafit; Riomont; Slimbant
Application Notes
Rimonabant is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. It is an inverse agonist for the cannabinoid receptor CB1. Its main avenue of effect is reduction in appetite.
Purity by HPLC
>98%
Hazard Compound
Refer MSDS for accurate information.
Overview
Rimonabant is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. It is an inverse agonist for the cannabinoid receptor CB1. Its main avenue of effect is reduction in appetite.
